Tencent and Gilead Sciences took part in a round that will fund clinical trials for three of Vaccitech's vaccine product candidates.

Ben Davey has departed from corporate venturing activities at Barclays for an executive position at a special purpose acquisition company.

The spinout’s technology was fundamental to Oxford’s covid vaccine, prompting OSI and Future Planet Capital to back a $168m round.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Baxter Healthcare was among the investors in the $65m first close of a private placement the biosimilar drug developer has pushed to $100m.

The Harju Elekter-backed ultracapacitor producer will develop automated production technology with funding secured from the German government.

GV and Salesforce Ventures joined existing investor Citi in a $45m round for the financial application development platform.

Medici Living Group has exited co-living spinoff Quarters through a purchase by Habyt, shortly after shutting the brand’s US operations earlier this year.

The Sioux Technologies-backed solar-powered vehicle developer has secured new funding as it prepares to complete the first deliveries of its cars later this year.

The regenerative therapy developer is based on research at University of Torino and has raised capital from returning backer V-Bio Ventures.